MAPK9 and cystic fibrosis: Moreover, JNK has been reported to be hyperactive in the lungs of a mice model of CF (Grassme et al., 2014), as is p38 MAPK (also activated by MLK3) in the lungs of CF patients (Berube et al., 2010), indicating that a SAPK pathway is activated under these conditions.